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Maternal Coxsackievirus B Induced Dysregulation of SUMOylation Processes
as a Potential Cause of Hypoplastic Left Heart Syndrome
Bailey Kemp, Sarah Severson, Dr. Rachel Johnson
Department of Science and Mathematics
University of Minnesota Morris, Morris, MN

Abstract
Hypoplastic Left Heart Syndrome (HLHS) is a
life-threatening congenital heart defect with unknown etiology.
Here we hypothesize that HLHS has etiologic roots in maternal
asymptomatic coxsackievirus B infection. Coxsackievirus has
been demonstrated to disrupt normal distribution of small
ubiquitin-like modifiers (SUMO) in the cell. The vital cardiac
transcription factor, Nkx2-5, has been shown to be dependent on
SUMOylation for proper function. Specifically, co-localization
of SUMO and Nkx2.5 has been identified, as well as decreased
SUMOylation associated with Nkx2-5 mutants. As Nxk2-5 is
essential for fetal heart development and mutations in the gene
for this vital transcription factor have been linked to HLHS,
disruption of the regular SUMOylation patterns of Nkx2-5 may
have severe consequences on cardiac development. Considering
this evidence, we propose a novel mechanism for the underlying
cause of HLHS. Specifically, we propose that asymptomatic
maternal coxsackievirus infection crosses the placental barrier
and disrupts SUMOylation processes during fetal development.
This, in turn alters the function of Nkx2-5, ultimately leading to
underdevelopment of the fetal heart and cardiac anomalies such
as Hypoplastic Left Heart Syndrome.

Background
Hypoplastic Left Heart Syndrome (HLHS) is characterized by
moderate to severe underdevelopment of the left side of the heart and the
aorta, and is estimated to affect about 960 infants born in the United states
every year. While several genetic and environmental components have
been identified as potential factors in the development of this birth defect,
the underlying cause of HLHS is still unknown [1].
Viral infections during pregnancy can cause various birth defects.
Coxsackieviruses, classified as single-stranded RNA enteroviruses, have
been linked to heart defects, mostly through case studies. Many infections
are asymptomatic and can often go completely undetected [3]. While there
is evidence that maternal coxsackievirus infection during pregnancy can
cross the placental barrier and lead to fetal infection, little is known about
the viral and cellular mechanisms that may play a role in the etiology of
fetal heart anomalies.
To propose a possible mechanism by which coxsackievirus
infection can lead to HLHS, we consider the evidence that HLHS is
associated with mutations in the gene for the cardiac transcription factor
Nkx2-5. This evolutionarily-conserved gene is vital for development of the
heart, and has been linked to several congenital heart defects [6]. There is
evidence that the function of Nkx2-5 is dependent on modification by small
ubiquitin-like modifiers (SUMO), and thus, proper SUMOylation processes
are essential for normal fetal heart development [7]. There is also evidence
that coxsackievirus infection causes changes in the usual aggregation
patterns of SUMO-1 and the related enzymes involved in SUMOylation
[8]. Combining this information, we suggest that an early-term maternal
coxsackievirus B infection represses the function of Nkx2-5 via
dysregulation of SUMO.

Hypothesis
We hypothesize that a maternal asymptomatic
coxsackievirus B infection causes alteration of SUMOylation
patterns in the fetus, which results in functional repression of the
transcription factor Nkx2-5, leading to underdevelopment of the
fetal heart and ultimately Hypoplastic Left Heart Syndrome.

SUMO/Nkx2-5 Co-Localization

Figure 1: SUMO/Nkx2-5 Co-localization
Immunohistochemistry of E9.5 embryos show SUMO-1 and SUMO-2
expressed broadly. This expression of SUMOylation overlaps with regions
that show Nkx2-5 expression as well. These regions are from the Second
Heart Field (SHF), including the outflow tract (oft) and lateral mesoderm
(lm). This exemplifies co-localization of SUMO and Nkx2-5 within the
heart, suggesting interaction between the two.
Costa MW, Lee S, Furtado MB, Xin L, Sparrow DB, et al. 2011. Complex SUMO-1
Regulation of Cardiac Transcription Factor Nkx2-5. PLoS ONE 6(9):
e24812. doi:10.1371/journal.pone.0024812

Rationale
Nkx2-5 is a homeobox transcription factor demonstrated to be essential for
normal cardiac development, as it is one of the beginning factors of a large
transcriptional cascade, including cardiomyocyte and chamber identity, as well as
asymmetry of the heart [9]. Due to its role in cardiac development, Nkx2-5
mutations have been associated with multiple congenital heart diseases, as well as
directly identified in patients with HLHS [6, 11].
One mechanism by which Nkx2-5 regulation occurs is via small
ubiquitin-like modifiers (SUMO). [7]. Specifically, SUMO-1 binds to target
proteins as part of an enzymatic cascade similar to that of ubiquitin. In the context
of heart development, SUMO has been identified as a key regulator, as both
SUMO-1 and SUMO-2 mRNA have been found in the developing heart tube,
chamber myocardium and the cardiac genes it targets. Additionally, SUMO has
been found to be directly associated with Nkx2-5. For example, Costa et al.
performed a western blot to reveal Nkx2-5 and SUMO cofactors, as well as an
immunoprecipitation with Nkx2-5 and SUMO-1 resulting in Nkx2-5 SUMOylated
bands and SUMOylated Nkx2-5 cofactors. Similarly, an immunohistochemistry
revealed co-localization of Nkx2-5 and SUMO-1 in embryonic secondary heart
fields. Specifically, Lysine 51 of Nkx2-5 was confirmed as a site of SUMOylation
[7].
Furthermore, Nkx2.5 has been identified to be dependent on SUMO, rather
than merely co-localized. For example, several mutated variants of human Nkx2-5
previously associated with CHD’s were identified to have a 50-80% decrease in
SUMOylation [12]. In mouse models, SUMOylation-deficient Nkx2-5 mutants
caused multiple cardiac anomalies [12]. While the relationship between SUMO and
Nkx2-5 is not fully defined, it is clear that alteration of the SUMOylation processes
could contribute to decreased Nkx2-5 transcriptional activity.
A potential cause for an interruption of SUMOylation is proposed to be
coxsackievirus B due to its association with SUMO disruption. In a study conducted
by Gomes et. al., SUMO-1 was found to be heavily redistributed in coxsackievirus
infected cells as opposed to controls [8]. While SUMO usually aggregates around
the nucleus in non-infected cells, coxsackievirus infection has been shown to cause
significant dispersion of SUMO around the cell. The enzyme UBC9, which is
necessary for SUMO-1 conjugation, was also found to be redistributed from the
normal aggregation patterns [8]. As coxsackie virus can cross the placental barrier
and transplacentally affect the developing fetus, it can result in disrupted
SUMOylation in the fetus [14]. As described above, SUMOylation plays a vital role
in the proper function of Nkx2-5. Therefore, the alteration of SUMO-1 and its
related enzymes caused by coxsackievirus infection may play a significant role in
the development of HLHS.

CHD-Associated Nkx2-5 Mutants with Irregular SUMOylation

Coxsackievirus Disrupts SUMO

Investigating interruption of Nkx2-5 SUMOylation via coxsackievirus
as a possible cause of HLHS offers a novel avenue to further explore the
etiology of this birth defect. Not only is SUMO a regulator of Nkx2-5, but it is
also involved with other transcription factors associated with HLHS, such as
Notch1. Because of this, SUMO should be explored further as a possible
component of heart development. As HLHS is fatal without a complex
three-part surgery, further understanding of possible etiological roots of this
condition is necessary. Given these conclusions, this hypothesis not only
introduces a viral infection relatively unexplored as a cause of HLHS, but also
explores a potential mechanism that may play a role in abnormal heart
development. Further investigation into this possible mechanism will allow
heightened understanding of HLHS and contribute to the identification of a
cause, and in effect, lead to possible preventative solutions or treatment.
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Figure 3: Coxsackievirus disrupts SUMO
SUMO-1 is normally aggregated around the nucleus. Upon
coxsackievirus B5 infection, SUMO-1 disperses throughout the cell.
The cells were stained via immunofluorescence (left) and DAPI (right).
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Innovation
While coxsackievirus infection during pregnancy has been associated
with several birth defects such as neurodevelopment delays and early-onset
diabetes mellitus, to our knowledge the effect of this virus on HLHS etiology
has not been directly studied. However, there have been several case studies
published that suggest a possible link between coxsackievirus infection and
heart defects. Our hypothesis not only provides a possible innovative
underlying cause - maternal viral infection - but also provides the possible
mechanisms by which this infection affects heart development: dysregulation
of SUMOylation of the vital transcription factor, Nkx2-5. While Nkx2-5 has
been previously linked to HLHS, SUMOylation, as a source of epigenetic
regulation, has not been explored in the context of HLHS. By providing a
mechanism for the cause of this birth defect via coxsackievirus and
disruption of SUMOylation, this hypothesis offers an innovative approach
that has not yet been explored in the context of HLHS.
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Figure 2: CHD-associated Nkx2-5 mutants display irregular SUMO modifications
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